Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Reagents & consumables and equipment are used for many testing pathways within the laboratory including regional patients for urgent cancer services such as lung, colorectal and haematological malignancies and rare disease disorders such Cystic Fibrosis
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Life Technologies Ltd | SC083107 | £912,780 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £912,780 initial term | 1 single bid — no competition | Life Technologies Ltd | active |
Weightings from the notice.
Government spending data: This supplier has received £1,064,370,902 in 3,313 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, Police Scotland, Manchester University NHS Foundation Trust, DEFRA and 8 more public bodies (2016-07-25 to 2026-03-30). View full payment history →